In the context of the increasing use of artificial intelligence (AI) tools to support writing, editing, and analysis in scientific articles, I wonder:

  • Are high-impact journals (measured by Impact Factor or Eigenfactor Score) more likely to explicitly reject the use of AI in their author guidelines?
  • Is this stance more common in niche biomedical journals or in broader multidisciplinary journals (e.g., Nature, Science, The Lancet)?
  • Are there specific examples of recent editorial policies regulating this topic in biomedical journals?
  • I aim to understand whether the explicit rejection of AI use is associated with journal prestige or with ethical, methodological, or transparency concerns in scientific publishing.

    PS: Any references to current editorial guidelines would be highly useful for advancing my research.

    More Gonzalo Briceño-Mayorga's questions See All
    Similar questions and discussions